COVID-19
European countries wary about confronting China over COVID-19 death figures
April 24, 2020Medical Communications COVID-19, China, coronavirus
National security experts in the UK and US believe China is underreporting the true amount of COVID-19 deaths, but European …
Trump widely criticised for suggesting patients could receive injections of disinfectant as COVID-19 cure
April 24, 2020Medical Communications COVID-19, coronavirus
President Donald Trump stunned the medical community by suggesting disinfectant and UV light could be used to treat patients suffering …
Socially disruptive measures will exist in Britain until at least the end of the year
April 23, 2020Business Services Britian COVID-19, COVID-19, coronavirus
England’s Chief Medical Officer Chris Whitty has said that the UK will have to live with some form of socially …
Cheaper Canadian drug imports continue to be seized by the FDA
April 23, 2020Business Services COVID-19, Canada, FDA, coronavirus, insulin
Seizures of Canadian drugs being sent to American patients have been stepped up by the FDA. This is according to …
BARDA director abruptly leaves post, claims he was ousted over pushback to hydroxychloroquine
April 23, 2020Business Services COVID-19, HHS, coronavirus
Rick Bright has claimed that he has been forced out of his position as the Director of the US Biomedical …
Pharmafile.com’s weekly COVID-19 news round-up
April 22, 2020Research and Development COVID-19, coronavirus, hydroxychloroquine
Hydroxychloroquine has faced setbacks as a potential COVID-19 treatment, as it failed a clinical trial in France and a study …
First in-home COVID-19 testing kit approved by the FDA
April 22, 2020Research and Development COVID-19, Testing kits, coronavirus, testing swabs
The US Food and Drug Administration have granted emergency clearance to the first in-home COVID-19 testing kit. The nasal swab …
National Institutes of Health says COVID-19 patients should not take hydroxychloroquine
April 22, 2020Research and Development COVID-19, coronavirus, hydroxychloroquine
Experts at the US National Institutes of Health (NIH) have drafted treatment guidelines for the use of hydroxychloroquine in COVID-19 …
Deaths in England and Wales hit 20 year high due to COVID-19 fatalities
April 21, 2020Manufacturing and Production COVID-19, COVID-19 UK, coronavirus, coronavirus uk
Deaths in England and Wales have hit a 20 year high, boosted by fatalities from the COVID-19 coronavirus. The Office …
FDA to take steps to ease shortages of drugs for COVID-19 patients on ventilators
April 21, 2020Manufacturing and Production COVID-19, Ventilators, coronavirus
The FDA is to allow small compound pharmacies to fill the shortages of medicines needed for patients with COVID-19 who …
Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial
April 20, 2020Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir
A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …
English COVID-19 cases to be tracked by ethnicity
April 20, 2020Sales and Marketing African-Americans, BAME, COVID-19, coronavirus
Cases of coronavirus are set to be tracked by ethnicity in England following an announced government review. The governments have …
Hydroxychloroquine fails COVID-19 clinical trial in France
April 20, 2020Sales and Marketing COVID-19, chloroquine, coronavirus, hydroxychloroquine
The malaria treatment hydroxychloroquine is facing further scrutiny as a coronavirus treatment after failed trials in France. The most recent …
FDA cautions that drug reviews will be slower due to COVID-19
April 17, 2020Medical Communications COVID-19, FDA, coronavirus
The FDA has warned that they may not be able to sustain its current levels of timely reviews and approvals …
US Government’s BARDA to fund Moderna’s coronavirus vaccine by $483m
April 17, 2020Medical Communications, Research and Development BARDA, COVID-19, Moderna, coronavirus, pharma
Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
